Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
Celia Perales,1,2,* Qian Chen,1,2,* Maria Eugenia Soria,1 Josep Gregori,1–3 Damir Garcia-Cehic,1,2 Leonardo Nieto-Aponte,4 Lluis Castells,1,2 Arkaitz Imaz,5 Meritxell Llorens-Revull,1 Esteban Domingo,2,6 Maria Buti,1,2,7 Juan Ignacio Esteban,1,2,7 Francisco Rodriguez-Frias,2,4,7 Josep Quer...
Main Authors: | Perales C, Chen Q, Soria ME, Gregori J, Garcia-Cehic D, Nieto-Aponte L, Castells L, Imaz A, Llorens-Revull M, Domingo E, Buti M, Esteban JI, Rodriguez-Frias F, Quer J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-11-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/baseline-hepatitis-c-virus-resistance-associated-substitutions-present-peer-reviewed-article-IDR |
Similar Items
-
Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment
by: Amer F, et al.
Published: (2019-09-01) -
Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients
by: Meritxell Llorens-Revull, et al.
Published: (2021-10-01) -
Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype
by: von Massow G, et al.
Published: (2019-04-01) -
Ras Isoforms from Lab Benches to Lives—What Are We Missing and How Far Are We?
by: Arathi Nair, et al.
Published: (2021-06-01) -
A Focused Review of Ras Guanine Nucleotide-Releasing Protein 1 in Immune Cells and Cancer
by: Tu Chun Hsu, et al.
Published: (2023-01-01)